Elisabeth Crönert-Bendell
Corporate Officer/Principal bij RHYTHM PHARMACEUTICALS, INC.
Profiel
Elisabeth Crönert-Bendell is currently the Senior Vice President & Head-Strategy at Rhythm Pharmaceuticals, Inc. She previously worked as a Senior Vice President at Sanofi and as the Head-Neuroscience Business Franchise at Kyowa Kirin International Plc.
Dr. Crönert-Bendell holds an MBA from INSEAD.
Actieve functies van Elisabeth Crönert-Bendell
| Bedrijven | Functie | Begin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2021 |
Eerdere bekende functies van Elisabeth Crönert-Bendell
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Elisabeth Crönert-Bendell
| INSEAD | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANOFI | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
